Lymphedema in Chronic Venous Insufficiency and Physical Procedures
DOI:
https://doi.org/10.5457/ams.v39i1%20Suppl..197Keywords:
lymphedema, chronic venous insufficiency, physical proceduresAbstract
Lymphedema is difficult, chronic, progressive, and prolonged illness with an uncertain therapeutic outcome. Lymphedema in chronic venous insufficiency (CVI), is by its ethiology a secundary illness, resulting from the dysfunction of the lymphatic and depending on the degree of CVI. This lymphedema can be transitory or persistent, acute or chronic with or without pathological changes in skin. CVI lymphedema occurs as a result of venous hypertension i.e. pathological reflux of venous blood and an increase in the mean capillary pressure in microcirculation of skin venules, which causes the venous route. The venous route impedes lymph reabsorption which upon the exhaustion of compensatory mechanisms leads to the lymph route and the occurrence of clinical lymphedema. Lymphedema therapy in CVI is directly dependent on the treatment of CVI, but to date these disorders are treated but not cured and it is correct to talk about treatment or help. Physical treatments include the application of: physical procedures such as vacusac, vasculator, magnetic, electrical, dosed kinezitherapy, laser, hyperbaric oxygen therapy (HBOT), thermomineral water of indifferent water temperature. Physical therapy contributes to the improvement and development of collateral flow and improved venous drainage with venous insufficiency. Clinically there is decrease in edema, improved trophic, reduced hyperpigmentation, reductions in dermatoflebosclerotic changes, reduced pain which ultimately improves the quality of life of these patients.
Downloads
Issue
Section
License
Copyright transfer
The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.
